Company: NOTV
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0001628280-25-039017
Chunk: 157

Company: Inotiv, Inc.
Filing Date: 2025-08-07
Form: 10-Q
Item: Part II, Item 8
Chunk 157
---
 as of March 14, 2024. Any common shares subject to an award under the 2024 Plan or 2018 Plan that expires, is forfeited or cancelled, is settled for cash or exchanged will become available for future awards under the 2024 Plan. Following the shareholders' approval of the 2024 Plan, awards can no longer be granted under the 2018 Plan. The Company currently grants equity awards from the 2024 Plan. As of June 30, 2025, 914,941 shares remained available for grants under the 2024 Plan.The Company expenses the estimated fair value of stock options, restricted stock and restricted stock units over the vesting periods of the grants. The Company recognizes expense for awards subject to graded vesting using the straight-line attribution method and forfeitures, as they are incurred. Stock based compensation expense for the three months ended June 30, 2025 and 2024, was $1,439 and $1,337, respectively. Stock based compensation expense for the nine months ended June 30, 2025 and 2024, was $4,644 and $5,118, respectively.Loss per ShareThe Company computes basic loss per share using the weighted average number of common shares outstanding. The Company computes diluted loss per share using the if-converted method for preferred shares and convertible debt, if any, and the treasury stock method for stock options and restricted stock units. 

31

The following table reconciles the numerator and denominator in the computations of basic and diluted loss per share:Three Months EndedJune 30,Nine Months EndedJune 30,2025202420252024Numerator:Consolidated net loss$(17,577)$(26,087)$(60,073)$(89,994)Less: Net loss attributable to noncontrolling interests— — — (440)Net loss attributable to common shareholders(17,577)(26,087)(60,073)(89,554)Denominator:Weighted-average shares outstanding - Basic (in thousands)34,35325,99331,81125,862Weighted-average shares outstanding - Diluted (in thousands)34,35325,99331,81125,862Anti-dilutive common share equivalents110,7125,45110,7125,4511As of June 30, 2025, anti-dilutive common share equivalents are comprised of stock options, restricted stock units, 2,859,306 common